TIBER CREEK GROUP

Lobbying for VERTEX PHARMACEUTICALS · Global biotechnology company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $80,000.00 income · posted Apr 19, 2025

Bills named in this filing 2

Lobbying activity 2

Health Issues

Issues related to drug pricing; Issues related to H.R. 7142/S. 3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Defense

Issues related to opioid alternatives.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.